While the percentages of CD57+ CD8 T cells were significantly increased in patients with liver disease, as a single marker, it was not sufficient to distinguish patients with and without this manifestation and was inferior to the more established investigation of reduced naïve CD4 T cells. This evidence concerns the gene CD8A and liver disorder.